System for parenteral administration of agent

Claim 2

A parenteral delivery system for administering a beneficial agent formulation to an animal, the system comprising: (a) a primary path for the flow of a parenterally acceptable fluid therethrough; (b) a formulation chamber in the primary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the primary path into the formulation chamber; (3) a beneficial agent in the formulation chamber that forms an agent formulation with fluid that enters the formulation chamber; (4) a film extended from the top to the bottom of the formulation chamber in the formulation chamber; said film separating said agent from the flow path and comprising releasing means that aids in controlling the rate of release of beneficial agent from the formulation chamber; (5) an outlet for letting an agent formulation leave the formulation chamber; (c) a secondary path for the flow of a parenterally acceptable fluid therethrough; (d) a formulation chamber in the secondary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the secondary path into the formulation chamber; (3) a beneficial agent in the formulation chamber that forms an agent formulation with fluid that enters the formulation chamber; (4) a film extended from the top to the bottom of the formulation chamber in the formulation chamber, said film separating said agent from the flow path and comprising releasing means that aids in controlling the rate of release of beneficial agent from the formulation chamber; (5) an outlet for letting an agent formulation leave the formulation chamber; and, (e) a common path in communication with the primary path and in communication with the secondary path for receiving agent formulation, which common path when the system is in use is in communication with the animal for administering beneficial agent formulation thereto.

Claim 3

The parenteral delivery system for administering the beneficial agent formulation according to claim 1, wherein the beneficial agent is placed to the side of the film.

Claim 4

The parenteral delivery system for administering the beneficial agent formulation according to claim 1, wherein the formulation chamber is in communication with a drip chamber.

Claim 5

A parenteral delivery system for administering a beneficial agent formulation to an animal, the system comprising: (a) a primary path for the flow of a parenterally acceptable fluid therethrough; (b) a formulation chamber in the primary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the primary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial agent in the formulation chamber that forms an agent formulation with fluid that enters the formulation chamber; (4) a fluid permeable film in the formulation chamber to the side of the inlet that confines the beneficial agent therein, said film providing releasing means for said agent; (5) an outlet for letting an agent formulation leave the formulation chamber; (c) a secondary path for the flow of a parenterally acceptable fluid therethrough; (d) a formulation chamber in the secondary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the secondary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial agent in the formulation chamber that forms agent formulation with fluid that enters the formulation chamber; (4) a fluid permeable film in the formulation chamber to the side of the inlet that confines the beneficial agent therein, said film providing releasing means for said agent; (5) an outlet for letting an agent formulation leave the formulation chamber; and, (e) a common path in communication with the primary path and in communication with the secondary path for receiving agent formulation, which common path when the system is in use is in communication with the animal for administering beneficial agent formulation thereto.

Claim 6

A parenteral delivery system for administering a beneficial agent formulation to an animal, the system comprising: (a) a primary path for the flow of a parenterally acceptable fluid therethrough; (b) a formulation chamber in the primary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the primary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial agent in the formulation chamber that forms an agent formulation with fluid that enters the formulation chamber; (4) a fluid permeable film in the formulation chamber to the side of the inlet that confines the beneficial agent therein, said film providing releasing means for said agent; (5) an outlet for letting an agent formulation leave the formulation chamber; (c) a secondary path for the flow of a parenterally acceptable fluid therethrough; (d) a formulation chamber in the secondary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the secondary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial agent in the formulation chamber that forms agent formulation with fluid that enters the formulation chamber; (4) a fluid permeable film in the formulation chamber to the side of the inlet that confines the beneficial agent therein, said film providing releasing means for said agent; (5) an outlet for letting an agent formulation leave the formulation chamber; and, (e) a common path in communication with the primary path and in communication with the secondary path for receiving agent formulation, which common path when the system is in use is in communication with the animal for administering beneficial agent formulation thereto.

Claim 7

The parenteral delivery system for administering the beneficial agent formulation according to claim 4, wherein the formulation chamber is in communication with a drip chamber.

Claim 8

An intravenous delivery system for administering a beneficial drug formulation to an animal, the system comprising: (a) a primary path for the flow of an intravenously acceptable fluid therethrough; (b) a formulation chamber in the primary path, the formulation comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the primary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid, beneficial drug in the formulation chamber that forms a drug formulation with fluid that enters the formulation chamber; (4) a film in the formulation chamber that aids in governing the rate of release of drug formulation from the formulation chamber, said film releasing the beneficial drug formulation by microporous, diffusion or osmotic physical chemical mechanisms. (5) an outlet for letting an agent formulation leave the formulation chamber; (c) a secondary path for the flow of an intravenously acceptable fluid therethrough; (d) a formulation chamber in the secondary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the secondary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial drug in the formulation chamber that forms a drug formulation with fluid that enters the formulation chamber; (4) a film in the formulation chamber that aids in governing the rate of release of drug formulation from the formulation chamber, said film formed of a nontoxic material that releases the beneficial drug formulation by microporous, diffusion or osmotic physical-chemical mechanisms; (5) an outlet for letting an agent formulation leave the formulation chamber; and, (e) a common path in communication with the primary path and in communication with the secondary path for receiving drug formulation, which common path when the system is in use is in communication with the animal for administering beneficial drug formulation thereto.

Claim 9

An intravenous delivery system for administering a beneficial drug formulation to an animal, the system comprising: (a) a primary path for the flow of an intravenously acceptable fluid therethrough; (b) a formulation chamber in the primary path, the formulation comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the primary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid, beneficial drug in the formulation chamber that forms a drug formulation with fluid that enters the formulation chamber; (4) a film in the formulation chamber that aids in governing the rate of release of drug formulation from the formulation chamber, said film releasing the beneficial drug formulation by microporous, diffusion or osmotic physical chemical mechanisms. (5) an outlet for letting an agent formulation leave the formulation chamber; (c) a secondary path for the flow of an intravenously acceptable fluid therethrough; (d) a formulation chamber in the secondary path, the formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet for letting fluid from the secondary path into the formulation chamber; (3) about 5 milligrams to 20 grams of a solid beneficial drug in the formulation chamber that forms a drug formulation with fluid that enters the formulation chamber; (4) a film in the formulation chamber that aids in governing the rate of release of drug formulation from the formulation chamber, said film formed of a nontoxic material that releases the beneficial drug formulation by microporous, diffusion or osmotic physical-chemical mechanisms; (5) an outlet for letting an agent formulation leave the formulation chamber; and, (e) a common path in communication with the primary path and in communication with the secondary path for receiving drug formulation, which common path when the system is in use is in communication with the animal for administering beneficial drug formulation thereto.

Claim 10

The intravenous delivery system for administering the beneficial drug formulation according to claim 6, wherein the formulation chamber is in communication with a drip chamber.